Paudel Atmika, Hamamoto Hiroshi, Panthee Suresh, Sekimizu Kazuhisa
Teikyo University Institute of Medical Mycology.
Drug Discov Ther. 2016;10(3):123-8. doi: 10.5582/ddt.2016.01041.
The current trend of increasing infections by multidrug-resistant pathogens requires the discovery of novel antimicrobial agents with new target and selective toxicity towards pathogens. Menaquinone is a component of electron transport chains in a majority of anaerobic bacteria and Gram-positive bacteria. Due to its exclusivity in bacteria, menaquinone is thought to be a potential target for development of therapeutically effective antibacterial agents without side effects. In this review, we summarize inhibitors of menaquinone biosynthesis and antibiotics directly targeting menaquinone in bacteria.
目前多重耐药病原体感染不断增加的趋势,需要发现具有新靶点且对病原体具有选择性毒性的新型抗菌剂。甲萘醌是大多数厌氧菌和革兰氏阳性菌电子传递链的组成部分。由于其在细菌中的独特性,甲萘醌被认为是开发无副作用的治疗有效抗菌剂的潜在靶点。在本综述中,我们总结了甲萘醌生物合成的抑制剂以及直接靶向细菌中甲萘醌的抗生素。